Your SlideShare is downloading. ×
Global pharmaceutical survey 2013 2014 - market trends, marketing spend and sales strategies in the global pharmaceutical industry
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Global pharmaceutical survey 2013 2014 - market trends, marketing spend and sales strategies in the global pharmaceutical industry

529

Published on

www.reportscorner.com …

www.reportscorner.com
Reports Corner has added “Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” to its latest reports offering. lease visit the link (https://www.reportscorner.com/report_detail.php?r_id=9824 )

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
529
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. www.reportscorner.comReports Corner has added “Global Pharmaceutical Survey 2013-2014 - Market Trends, MarketingSpend and Sales Strategies in the Global Pharmaceutical Industry” to its latest reports offering.lease visit the link (https://www.reportscorner.com/report_detail.php?r_id=9824 )Product Synopsis “Global Pharmaceutical Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies inthe Global Pharmaceutical Industry” is a new report by ICD Research that analyzes howpharmaceutical industry companies media spend, marketing and sales strategies and practices, andbusiness planning are set to change in 2013-2014. Additionally, this report also presentscomparative analysis between four years of survey results (wherever applicable). This reportprovides the current size of the marketing and advertising budgets of global pharmaceuticalindustry suppliers and how spending by global pharmaceutical industry suppliers will change,providing an insight into global marketing behaviour. In addition, the report identifies futuregrowth of global pharmaceutical industry buyers and suppliers and MandA activity. This report notonly grants access to the opinions and strategies of business decision makers and competitors, butalso examines their actions surrounding business priorities. The report also provides access toinformation categorized by region, company type and sizes.”Introduction and LandscapeWhy was the report written?This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leadingglobal pharmaceutical industry executives. The report provides data and analysis on globalpharmaceutical industry suppliers media spend, marketing and sales strategies, and practices andbusiness planning within the global pharmaceutical industry. This report includes key topics such asmedia channel spending outlooks, media budgets, marketing agency selection criteria, businesschallenges, and sales tactics of leading suppliers within the global pharmaceutical industry. Thereport also identifies global pharmaceutical industry buyers and suppliers future growth, MandAand investment expectations. Most secondary research reports are based on general industry driversand do not understand the industry executives attitude and changing behaviours, creating a gap inpresenting the business outlook of the industry. In an effort to bridge this gap, ICD Researchcreated this primary-research based report by gathering the opinions of multiple stake holders inthe value-chain of the global pharmaceutical industryWhat is the current market landscape and what is changing?The average size of the annual marketing budget of global pharmaceutical industry supplierrespondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.What are the key drivers behind recent market changes?In the process of choosing marketing agencies, the ability to target specific audience niches,strategic and tactical consulting, and the ability to generate leads or setup customer meetings areconsidered the most important factors by global pharmaceutical industry suppliers.What makes this report unique and essential to read?
  • 2. This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leadingpharmaceutical industry companies. This report provides the reader with a definitive analysis of theindustry outlook and explores how opportunities and demand are set to change in 2013-2014.Additionally, this report also presents comparative analysis between four years of survey results(wherever applicable). Furthermore, the report reveals the current size of pharmaceutical industrysuppliers marketing and advertising budgets and how expenditure by industry suppliers will change,providing insight into global marketing behavior. This report identifies the key marketing aims oforganizations and the sales strategies companies will adopt in order to adapt to market conditionsin 2013. Additionally, this chapter also aims to identify key amendments to marketing agencies thataid business generation, respondents criteria for marketing agency selection, and attitudes towardsmarketing and sales.Key Features and BenefitsProjects industry trends and revenue growth expectations in 2013.Drive revenues by understanding future product investment areas and key growth regions.Uncover key challenges and opportunities and identify key actions required to maintain and winbuyer business.Formulate effective sales and marketing strategies by identifying the overall size of the marketingbudgets of global pharmaceutical industry supplier companies.Identifies the key marketing aims of organizations and which sales strategies companies will beadopting to deal with market conditions in 2013-2014.Key Market IssuesChina, Brazil, and India are the important emerging markets to offer growth in 2013.Market uncertainty, responding to price pressure, rising competition, and regulatory changes arethe leading business concerns for the global pharmaceutical industry in 2013.The average size of the annual marketing budget of global pharmaceutical industry supplierrespondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.Social media and networking sites, email and newsletters, and conferences and events areexpected to have increased expenditure in 2013 as identified by 56%, 48%, and 44% of respondentsrespectively.Overall, competitor and market intelligence research, customer intelligence and analytics, andbusiness performance management solutions were identified as the marketing and sales solutionsmost expected to be invested in during 2013.Key HighlightsAn analysis of revenue growth expectations by senior level respondents reveals that 62% are moreoptimistic about their companys revenue growth in 2013.A significant percentage of pharmaceutical manufacturing industry respondents highlighted thatcapital expenditure towards new product development, employee training, and IT infrastructuredevelopment would increase in 2013. The top three priorities for global pharmaceutical industry buyer respondents in 2013 are newproducts and services, improve operational efficiency, and expand in current markets.
  • 3. A total of 49% of respondents from pharmaceutical manufacturing companies, 68% of respondentsfrom CRO and CMO companies, and 64% of respondents from pharmaceutical industry suppliercompanies anticipate an increase in their current workforce in 2013.Survey results show that respondents from the global pharmaceutical industry identified the US asoffering the highest growth potential among developed countries in 2013-2014.Table of Contents1 Introduction1.1 What is This Report About?1.2 Definitions1.3 Methodology1.4 Profile of Survey Respondents: Global Pharmaceutical Industry1.4.1 Global pharmaceutical industry: profile of buyer respondents1.4.2 Global pharmaceutical industry: profile of supplier respondents2 Executive Summary3 Global Pharmaceutical Industry Dynamics3.1 Revenue Growth Projections in the Global Pharmaceutical Industry3.1.1 Revenue growth projections by company type3.1.2 Revenue growth projections by region3.1.3 Revenue growth projections by company turnover3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents3.2 Future Developments in Business Structure in the Global Pharmaceutical Industry3.2.1 Future developments in business structure by buyers3.2.2 Future developments in business structure by suppliers3.2.3 Future developments in business structure by region3.2.4 Future developments in business structure by company turnover3.2.5 Future developments in business structure by senior level respondents3.3 Change in Leading Company Strategies in the Global Pharmaceutical Industry3.3.1 Change in leading company strategies by buyers3.3.2 Change in leading company strategies by suppliers3.3.3 Change in leading company strategies by region3.3.4 Change in leading company strategies by company turnover3.4 Merger and Acquisition (MandA) Activity Projections in the Global Pharmaceutical Industry3.4.1 MandA activity projections by buyers3.4.2 MandA activity projections by suppliers3.4.3 MandA activity projections by region3.4.4 MandA activity projections by company turnover3.4.5 MandA activity projections by purchasing decision authority3.4.6 Global pharmaceutical industry - expand abroad Vs MandA activity projections3.5 Estimation of Capital Expenditure in the Global Pharmaceutical Industry3.5.1 Estimation of capital expenditure by buyers3.5.2 Estimation of capital expenditure by suppliers3.5.3 Estimation of capital expenditure by region3.5.4 Estimation of capital expenditure by company turnover3.6 Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry3.6.1 Planned change in staff recruitment activity by buyers3.6.2 Planned change in staff recruitment activity by suppliers3.6.3 Planned change in staff recruitment activity by region3.6.4 Planned change in staff recruitment activity by company turnover
  • 4. 4 Global Pharmaceutical Industry Market Growth Outlook4.1 Global Pharmaceutical Industry: Demand in Emerging Markets4.1.1 Demand in emerging markets by buyers4.1.2 Demand in emerging markets by suppliers4.1.3 Demand in emerging markets by region4.1.4 Demand in emerging markets by company turnover4.2 Global Pharmaceutical Industry - Growth Projections in Developed Countries4.2.1 Growth projections in developed countries by buyers4.2.2 Growth projections in developed countries by suppliers4.2.3 Growth projections in developed countries by region4.2.4 Growth projections in developed countries by company turnover5 Threats and Opportunities for the Global Pharmaceutical Industry5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2013-20145.1.1 Leading business concerns for 2013-2014 by company type5.1.2 Leading business concerns for 2013-2014 by region5.1.3 Leading business concerns for 2013-2014 by company turnover5.2 Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business5.2.1 Actions to maintain and secure buyer business by buyers5.2.2 Actions to maintain and secure buyer business by region5.2.3 Actions to maintain and secure buyer business by company turnover5.2.4 Actions to maintain and secure buyer business by purchasing decision authority6 Global Pharmaceutical Industry - Supplier Marketing Spend Activity6.1 Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers6.1.1 Annual marketing budgets by region - global pharmaceutical industry suppliers6.1.2 Annual marketing budgets by company turnover - global pharmaceutical industry suppliers6.2 Planned Change in Marketing Expenditure Levels - Global Pharmaceutical Industry Suppliers6.2.1 Planned change in marketing expenditure by region - global pharmaceutical industry suppliers6.2.2 Planned change in marketing expenditure by turnover - global pharmaceutical industrysuppliers6.2.3 Planned change in marketing expenditure by decision making authority - globalpharmaceutical industry suppliers6.2.4 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 20136.3 Future Investment by Media Channel - Global Pharmaceutical Industry Suppliers6.3.1 Future investment by media channel by region - global pharmaceutical industry suppliers6.3.2 Future investment by media channel by company turnover - global pharmaceutical industrysuppliers6.4 Global Pharmaceutical Industry Suppliers Future Investment in Marketing and Sales6.4.1 Planned investment in marketing and sales technologies by region - global pharmaceuticalindustry suppliers6.4.2 Planned investment in marketing and sales by turnover: global pharmaceutical industrysuppliers7 Marketing and Sales Behaviors and Strategies in 2013-20147.1 Key Marketing Aims for 2013-2014 - Global Pharmaceutical Industry Suppliers7.1.1 Key marketing aims by region - global pharmaceutical industry suppliers7.1.2 Key marketing aims by company turnover - global pharmaceutical industry suppliers7.2 Essential Amendments to Marketing Activities in 2013-20147.2.1 Amendments to marketing activities by company turnover - global pharmaceutical industrysuppliers7.3 Critical Success Factors for Choosing a Marketing Agency7.3.1 Critical success factors for choosing a marketing agency by region
  • 5. 7.3.2 Critical success factors by company turnover - global pharmaceutical industry suppliers8 Appendix8.1 Global Pharmaceutical Industry Survey Results- Closed Questions8.2 Methodology8.3 Contact us8.4 About ICD Research8.5 DisclaimerTable of ContentsTable 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010-2013Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010-2013Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry(%), 2013Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry(%), 2013Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry(%), 2013Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry(%), 2013Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - GlobalPharmaceutical Industry (%), 2013Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),2013Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),2013Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),2013Table 21: MandA Activity Projections - Global Pharmaceutical Manufacturers Industry (%), 2010-2013Table 22: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013Table 23: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013Table 24: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013Table 25: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013Table 26: Global Pharmaceutical Industry MandA Activity Projections by Purchasing DecisionAuthority (%), 2013Table 27: Global Pharmaceutical Industry - Expand Abroad vs. MandA Activity Projections(%), 2013Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
  • 6. Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),2013Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity(%), 2013Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region(%), 2013Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity byTurnover (%), 2013Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),2013Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),2013Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries(%), 2013Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countriesby Turnover (%), 2013Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010-2013Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013-2014Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses(%), 2013Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),2013Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing DecisionAuthority (%), 2013Table 50: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013Table 51: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013Table 52: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%),2013Table 53: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%),2010-2013Table 54: Planned Change in Marketing Expenditure Levels by Region (%), 2013Table 55: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2013Table 56: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013Table 57: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2013Table 58: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%), 2013Table 59: Planned Investment in Marketing and Sales Technologies - Global Pharmaceutical IndustrySuppliers (%), 2013Table 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013Table 61: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%), 2013Table 62: Amendments to Marketing Activities by Company Turnover - Global PharmaceuticalIndustry Suppliers (%), 2013Table 63: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2010-2013Table 64: Survey Results - Closed Questions
  • 7. List of FiguresFigure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%),2010-2013Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry(%), 2013Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry(%), 2013Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry(%), 2013Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry(%), 2013Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),2013Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),2013Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),2013Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%),2013Figure 13: MandA Activity Projections - Global Pharmaceutical Industry (%), 2013Figure 14: MandA Activity Projections - Global Pharmaceutical Manufacturers Industry (%), 2010-2013Figure 15: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013Figure 16: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013Figure 17: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013Figure 18: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013Figure 19: Global Pharmaceutical Industry MandA Activity Projections by Purchasing DecisionAuthority (%), 2013Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs MandA Activity Projections (%), 2013Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),2013Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity(%), 2013Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region(%), 2013Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity byTurnover (%), 2013Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
  • 8. Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),2013Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),2013Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries(%), 2013Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countriesby Region (%), 2013Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013-2014Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses(%), 2013Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),2013Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013Figure 48: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013Figure 49: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013Figure 50: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%),2013Figure 51: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%),2010-2013Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2013Figure 53: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013Figure 54: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%),2013Figure 55: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Region (%),2013Figure 56: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Turnover(%), 2013Figure 57: Planned Investment in Marketing and Sales Technologies - Global PharmaceuticalIndustry Suppliers (%), 2013Figure 58: Planned Investment in Marketing and Sales Technologies by Region - GlobalPharmaceutical Industry Suppliers (%), 2013Figure 59: Planned Investment in Marketing and Sales Technologies by Company Turnover - GlobalPharmaceutical Industry Suppliers (%), 2013Figure 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013Figure 61: Key Marketing Aims by Region - Global Pharmaceutical Industry Suppliers (%), 2013Figure 62: Key Marketing Aims by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013Figure 63: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%) , 2013Figure 64: Amendments to Marketing by Turnover - Global Pharmaceutical Industry Suppliers (%) ,2013Figure 65: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2013Figure 66: Critical Success Factors by Region - Global Pharmaceutical Industry Suppliers (%), 2013Figure 67: Critical Success Factors by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013

×